Literature DB >> 34079311

Use of Eye Care Service and Associated Factors Among Adult Diabetic Patients Attending at Diabetic Clinics in Two Referral Hospitals, Northeast Ethiopia.

Toyba Mohammed Ahmed1, Ketemaw Zewdu Demilew2, Melkamu Temeselew Tegegn2, Mohammed Seid Hussen2.   

Abstract

PURPOSE: The objective of this study was to determine the proportion of use of eye care service and associated factors among adult diabetic patients attending diabetic clinics in two referral hospitals, Northeast Ethiopia, 2020.
METHODS: A hospital-based cross-sectional study was carried out with a sample size of 546 at Dessie and Debre-Birhan Comprehensive Specialized Hospitals from July 06 to August 14/2020. Systematic random sampling with a sampling fraction of 2 was employed to select study participants at outpatient departments in diabetic clinics. A pre-tested structured questionnaire, checklist, and visual acuity chart were used to collect the data. The collected data were entered into EPI-data version 4.4 and analyzed using Statistical Package for Social Sciences (SPSS) version 25. Binary logistic regression was fitted to identify the possible factors associated with the outcome variable, and the strength of association was expressed using an adjusted odds ratio at a 95% confidence interval. Variables with p-values of less than 0.05 were considered statistically significant.
RESULTS: A total of 531 adult patients with diabetes participated with a response rate of 97.3%. In this study, the proportion of use of eye care service within the past 1 year was 31.5% (95% CI: 27.5, 35.4). Age from 40 to 64 years (AOR=2.86, 95% CI; 1.43,5.70) and >65 years (AOR=3.15, 95% CI: 1.32,7.50), duration of diabetes 6-10 years (AOR=2.15, 95% CI: 1.26, 3.69) and >11 years (AOR=2.93, 95% CI: 1.51, 5.69), presence of visual symptoms (AOR=3.12, 95% CI: 1.56, 6.18), good attitude on the need of a regular eye checkup (AOR=2.87, 95% CI: 1.68, 4.94), and good knowledge about diabetic ocular complication (AOR=2.29, 95% CI: 1.33, 3.94) were positively associated with the use of eye care service.
CONCLUSION: The proportion of use of eye care service among adult diabetic patients was low. The use of eye care service was significantly and independently associated with older age, longer duration of diabetes, presence of visual symptoms, good attitude on the need of a regular eye checkup, and good knowledge about diabetic ocular complication. We recommend that the patients with diabetes should be taught about diabetic ocular complications and the importance of regular eye check-ups by health professionals to increase utilization of eye care services by patients with diabetes.
© 2021 Ahmed et al.

Entities:  

Keywords:  Northeast Ethiopia; diabetes mellitus; use of eye care service

Year:  2021        PMID: 34079311      PMCID: PMC8163631          DOI: 10.2147/DMSO.S311274

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.168


  25 in total

Review 1.  Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review.

Authors:  Daniel Shu Wei Ting; Gemmy Chui Ming Cheung; Tien Yin Wong
Journal:  Clin Exp Ophthalmol       Date:  2016-02-17       Impact factor: 4.207

2.  Eye care use among a high-risk diabetic population seen in a public hospital's clinics.

Authors:  Paul A Maclennan; Gerald McGwin; Christine Heckemeyer; Virginia R Lolley; Sandral Hullett; Jinan Saaddine; Sundar S Shrestha; Cynthia Owsley
Journal:  JAMA Ophthalmol       Date:  2014-02       Impact factor: 7.389

3.  Socioeconomic factors associated with visual impairment and ophthalmic care utilization in patients with type II diabetes.

Authors:  Jongnam Hwang; Christopher Rudnisky; Sarah Bowen; Jeffrey A Johnson
Journal:  Can J Ophthalmol       Date:  2015-04       Impact factor: 1.882

4.  Compliance with eye screening examinations among diabetic patients at a Tanzanian referral hospital.

Authors:  Musonda Mumba; Anthony Hall; Susan Lewallen
Journal:  Ophthalmic Epidemiol       Date:  2007 Sep-Oct       Impact factor: 1.648

Review 5.  Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.

Authors:  Tien Y Wong; Jennifer Sun; Ryo Kawasaki; Paisan Ruamviboonsuk; Neeru Gupta; Van Charles Lansingh; Mauricio Maia; Wanjiku Mathenge; Sunil Moreker; Mahi M K Muqit; Serge Resnikoff; Juan Verdaguer; Peiquan Zhao; Frederick Ferris; Lloyd P Aiello; Hugh R Taylor
Journal:  Ophthalmology       Date:  2018-05-24       Impact factor: 12.079

6.  Assessment of awareness of diabetic retinopathy and utilization of eye care services among Turkish diabetic patients.

Authors:  Ebru N Cetin; Mehmet Zencir; Semin Fenkçi; Fulya Akın; Cem Yıldırım
Journal:  Prim Care Diabetes       Date:  2013-04-29       Impact factor: 2.459

7.  Eye care utilization by older adults in low, middle, and high income countries.

Authors:  Claudia Vela; Elodie Samson; Maria Victoria Zunzunegui; Slim Haddad; Marie-Josée Aubin; Ellen E Freeman
Journal:  BMC Ophthalmol       Date:  2012-04-03       Impact factor: 2.209

Review 8.  Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review.

Authors:  P I Burgess; I J C MacCormick; S P Harding; A Bastawrous; N A V Beare; P Garner
Journal:  Diabet Med       Date:  2013-04       Impact factor: 4.359

9.  Predictors of uptake of eye examination in people living with diabetes mellitus in three counties of Kenya.

Authors:  Nyawira Mwangi; David Macleod; Stephen Gichuhi; Lawrence Muthami; Consuela Moorman; Covadonga Bascaran; Allen Foster
Journal:  Trop Med Health       Date:  2017-12-21

10.  Eye care utilization among diabetics in the South African National Health and Nutrition Examination Survey (SANHANES-1): a cross-sectional study.

Authors:  Kwadwo Owusu Akuffo; Akosua Kesewah Asare; Ronel Sewpaul; Natisha Dukhi; David Ben Kumah; Eldad Agyei-Manu; Emmanuel Kofi Addo; Priscilla Reddy
Journal:  BMC Res Notes       Date:  2020-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.